| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |